- Corporate Officers - S
- Sharp Shalini
Insider Trading History of Sharp Shalini
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sharp Shalini since 2007.
This trader's CIK number is 1377202.
At the time of last reporting, Sharp Shalini was the Director of Neurocrine Biosciences Inc. (stock ticker symbol NBIX).
Also see all insider trading activities at Neurocrine Biosciences Inc.
Note that in the past
Sharp Shalini also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Array Biopharma Inc (ARRY) by Sharp Shalini
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2018 | ARRY | 0 | $0 | 0 | $0 | 5,000 | $0 |
Yearly summary of insider trading at Ultragenyx Pharmaceutical Inc. (RARE) by Sharp Shalini
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2020 | RARE | 0 | $0 | 56,664 | $4,387,665 | 50,876 | $3,132,812 |
2019 | RARE | 0 | $0 | 14,800 | $1,036,000 | 43,843 | $204,437 |
2018 | RARE | 0 | $0 | 26,400 | $2,052,095 | 25,200 | $20,537 |
2017 | RARE | 0 | $0 | 36,000 | $3,004,536 | 36,000 | $29,340 |
2016 | RARE | 0 | $0 | 36,000 | $2,476,332 | 42,500 | $34,605 |
2015 | RARE | 0 | $0 | 43,708 | $3,851,894 | 13,000 | $10,595 |
2014 | RARE | 4,500 | $94,500 | 20,000 | $979,528 | 0 | $0 |
Yearly summary of insider trading at Nuvation Bio Inc. (NUVB) by Sharp Shalini
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2021 | NUVB | 0 | $0 | 0 | $0 | 25,000 | $0 |
Yearly summary of insider trading at Neurocrine Biosciences Inc (NBIX) by Sharp Shalini
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | NBIX | 0 | $0 | 0 | $0 | 1,435 | $0 |
Yearly summary of insider trading at Agenus Inc (AGEN) by Sharp Shalini
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | AGEN | 0 | $0 | 288 | $1,255 | 0 | $0 |
2012 | AGEN | 0 | $0 | 576 | $2,603 | 0 | $0 |
2011 | AGEN | 0 | $0 | 9,994 | $21,724 | 0 | $0 |
2010 | AGEN | 0 | $0 | 70,818 | $61,395 | 0 | $0 |
2009 | AGEN | 0 | $0 | 45,796 | $76,021 | 0 | $0 |
2007 | AGEN | 10,000 | $19,570 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Sharp Shalini:
1. Array Biopharma Inc (ARRY)
2. Ultragenyx Pharmaceutical Inc. (RARE)
3. Nuvation Bio Inc. (NUVB)
4. Neurocrine Biosciences Inc (NBIX)
5. Agenus Inc (AGEN)
Table 1. Insider trading of Array Biopharma Inc (ARRY) by Sharp Shalini
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2018-10-26 | ARRY | Option Ex | 5,000 | .00 | 0 |
Table 2. Insider trading of Ultragenyx Pharmaceutical Inc. (RARE) by Sharp Shalini
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2020-10-14 | RARE | Sale | 375 | 87.99 | 32,996 |
2020-08-17 | RARE | Option Ex | 11,357 | 62.18 | 706,212 |
2020-08-17 | RARE | Sale | 14,378 | 88.38 | 1,270,785 |
2020-06-04 | RARE | Sale | 2,564 | 74.01 | 189,761 |
2020-06-03 | RARE | Sale | 10,234 | 74.23 | 759,669 |
2020-06-04 | RARE | Option Ex | 2,564 | 48.43 | 124,174 |
2020-06-03 | RARE | Option Ex | 10,234 | 48.43 | 495,632 |
2020-05-19 | RARE | Sale | 7,128 | 73.32 | 522,624 |
2020-05-18 | RARE | Sale | 21,985 | 73.31 | 1,611,830 |
2020-05-19 | RARE | Option Ex | 7,128 | 59.50 | 424,116 |
2020-05-18 | RARE | Option Ex | 19,593 | 70.57 | 1,382,678 |
2019-09-16 | RARE | Option Ex | 31,843 | 3.83 | 122,117 |
2019-03-18 | RARE | Option Ex | 12,000 | 6.86 | 82,320 |
2019-03-18 | RARE | Sale | 14,800 | 70.00 | 1,036,000 |
2018-10-31 | RARE | Option Ex | 12,000 | .81 | 9,780 |
2018-09-25 | RARE | Option Ex | 3,350 | .81 | 2,730 |
2018-09-25 | RARE | Sale | 6,700 | 90.07 | 603,469 |
2018-06-07 | RARE | Option Ex | 3,350 | .81 | 2,730 |
2018-06-07 | RARE | Sale | 6,700 | 80.07 | 536,455 |
2018-05-30 | RARE | Sale | 13,000 | 70.17 | 912,171 |
2018-05-30 | RARE | Option Ex | 6,500 | .81 | 5,297 |
2017-03-02 | RARE | Option Ex | 12,000 | .81 | 9,780 |
2017-03-02 | RARE | Sale | 12,000 | 90.10 | 1,081,176 |
2017-02-27 | RARE | Sale | 12,000 | 80.14 | 961,680 |
2017-02-27 | RARE | Option Ex | 12,000 | .81 | 9,780 |
2017-02-27 | RARE | Sale | 12,000 | 80.14 | 961,680 |
2017-02-27 | RARE | Option Ex | 12,000 | .81 | 9,780 |
2016-12-23 | RARE | Option Ex | 6,500 | .81 | 5,265 |
2016-11-09 | RARE | Option Ex | 24,000 | .81 | 19,560 |
2016-11-09 | RARE | Sale | 24,000 | 72.51 | 1,740,192 |
2016-10-19 | RARE | Sale | 12,000 | 61.34 | 736,140 |
2016-10-19 | RARE | Option Ex | 12,000 | .81 | 9,780 |
2015-12-10 | RARE | Sale | 12,000 | 101.59 | 1,219,140 |
2015-12-10 | RARE | Option Ex | 12,000 | .81 | 9,780 |
2015-07-20 | RARE | Sale | 3,854 | 131.67 | 507,467 |
2015-07-20 | RARE | Sale | 3,854 | 131.67 | 507,467 |
2015-06-18 | RARE | Sale | 4,000 | 96.15 | 384,600 |
2015-05-18 | RARE | Sale | 4,000 | 79.43 | 317,720 |
2015-05-01 | RARE | Option Ex | 1,000 | .81 | 815 |
2015-04-20 | RARE | Sale | 4,000 | 61.87 | 247,460 |
2015-03-18 | RARE | Sale | 4,000 | 61.45 | 245,800 |
2015-02-18 | RARE | Sale | 4,000 | 54.32 | 217,284 |
2015-01-20 | RARE | Sale | 4,000 | 51.24 | 204,956 |
2014-12-18 | RARE | Sale | 4,000 | 44.82 | 179,288 |
2014-11-20 | RARE | Sale | 4,000 | 44.07 | 176,280 |
2014-10-20 | RARE | Sale | 4,000 | 46.02 | 184,080 |
2014-09-18 | RARE | Sale | 4,000 | 56.00 | 224,000 |
2014-08-18 | RARE | Sale | 4,000 | 53.97 | 215,880 |
2014-01-30 | RARE | Buy | 4,500 | 21.00 | 94,500 |
Table 3. Insider trading of Nuvation Bio Inc. (NUVB) by Sharp Shalini
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2021-02-10 | NUVB | Option Ex | 25,000 | .00 | 0 |
Table 4. Insider trading of Neurocrine Biosciences Inc (NBIX) by Sharp Shalini
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-05-22 | NBIX | Option Ex | 1,435 | .00 | 0 |
Table 5. Insider trading of Agenus Inc (AGEN) by Sharp Shalini
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-01-30 | AGEN | Sale | 288 | 4.36 | 1,255 |
2012-10-31 | AGEN | Sale | 288 | 4.40 | 1,267 |
2012-08-29 | AGEN | Sale | 288 | 4.64 | 1,336 |
2011-12-27 | AGEN | Sale | 2,853 | 2.14 | 6,105 |
2011-12-28 | AGEN | Sale | 1,711 | 2.09 | 3,575 |
2011-12-22 | AGEN | Sale | 1,548 | 2.19 | 3,390 |
2011-12-23 | AGEN | Sale | 795 | 2.20 | 1,746 |
2011-12-21 | AGEN | Sale | 3,087 | 2.24 | 6,908 |
2010-10-28 | AGEN | Sale | 1,500 | .96 | 1,440 |
2010-09-14 | AGEN | Sale | 2,000 | .91 | 1,824 |
2010-07-27 | AGEN | Sale | 1,520 | .93 | 1,407 |
2010-04-27 | AGEN | Sale | 1,950 | 1.16 | 2,262 |
2010-01-20 | AGEN | Sale | 63,848 | .85 | 54,462 |
2009-07-15 | AGEN | Sale | 13,271 | 1.76 | 23,396 |
2009-07-16 | AGEN | Sale | 32,525 | 1.62 | 52,625 |
2007-03-12 | AGEN | Buy | 5,000 | 1.95 | 9,735 |
2007-03-13 | AGEN | Buy | 5,000 | 1.97 | 9,835 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Sharp Shalini
(Director of Neurocrine Biosciences Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.